Aimei Health Technology Co., Ltd (AFJK)
NASDAQ: AFJK · Real-Time Price · USD
10.52
-0.08 (-0.75%)
Dec 20, 2024, 4:00 PM EST - Market closed
Company Description
Aimei Health Technology Co., Ltd does not have significant operations.
It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities.
It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.
Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
Aimei Health Technology Co., Ltd
Country | United States |
Founded | 2023 |
IPO Date | Dec 4, 2023 |
Industry | Shell Companies |
Sector | Financials |
CEO | Junheng Xie |
Contact Details
Address: 10 East 53rd Street, Suite 3001 New York, New York 10022 United States | |
Phone | 212 845 9945 |
Stock Details
Ticker Symbol | AFJK |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $10.00 |
CIK Code | 0001979005 |
ISIN Number | KYG013411098 |
SIC Code | 6770 |
Key Executives
Name | Position |
---|---|
Junheng Xie | Chief Executive Officer, Secretary and Director |
Heung Ming Wong | Chief Financial Officer and Director |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 13, 2024 | 8-K | Current Report |
Dec 3, 2024 | DEF 14A | Other definitive proxy statements |
Nov 21, 2024 | PRE 14A | Other preliminary proxy statements |
Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Nov 13, 2024 | 10-Q | Quarterly Report |
Nov 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Nov 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Oct 16, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Aug 9, 2024 | 10-Q | Quarterly Report |